Developing a vaccine to combat fungal infections
Official title: Task V31: Process Development for Panfungal Vaccine
Funded at Advanced Bioscience Laboratories, INC. · NIH-11087446 · Data updated 2026-11-12
This study is working on a new vaccine to help protect people from tough fungal infections that don't respond well to current treatments, and it aims to make sure the vaccine is safe and effective for future use.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | January 20, 2023 |
| Project end | July 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $45,370 |
| NIH project number | 272201800009I-P00001-759302300001-1 |
| Project ID | NIH-11087446 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at high risk for fungal infections, such as those with weakened immune systems or underlying health conditions.
✕Less likely to help
Patients who are not at risk for fungal infections or those who do not have any underlying health conditions may not benefit from this research.
What this research studies
This research focuses on creating a vaccine that targets various fungal infections, particularly those that are resistant to current treatments. It involves planning and optimizing the vaccine development process, ensuring compliance with manufacturing standards, and preparing for clinical trials. Patients may benefit from the development of new vaccines that could provide better protection against these infections. The research also includes regulatory support to facilitate the approval process with the FDA.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that significantly reduce the incidence of fungal infections, especially in patients with compromised immune systems.
How similar studies have gone: Other research has shown promise in developing vaccines for infectious diseases, indicating that this approach could be successful.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Fouts, Tim — Advanced Bioscience Laboratories, INC.
- Study coordinator: Fouts, Tim
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.